Health
Personalized genetic testing helps reduce adverse events following balloon angioplasty – News-Medical.Net
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 per cent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by 34 percent the number of serious adverse events following balloon angioplasty, a treatment for the most common form of heart disease.
For patients undergoing percutaneous coronary intervention (PCI)-; a non-surgical procedure where physicians inflate a balloon and place a metal stent in narrowed heart arteries to improve blood flow to the heart-;the choice of antiplatelet therapy can be critical …
-
Business18 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General10 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business21 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business17 hours agoHere’s what analysts expect for the BHP share price in the coming year